COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort

A. Tovchigrechko (Gaithersburg, United States of America), C. Chiang (Gaithersburg, United States of America), D. Khatry (Gaithersburg, United States of America), C. Emson (Gaithersburg, United States of America), D. Singh (Manchester, United Kingdom), J. Wedzichia (London, United Kingdom), G. Donaldson (London, United Kingdom), C. Brightling (Leicester, United Kingdom), D. Finch (Gaithersburg, United States of America), O. Vaarala (Gaithersburg, United States of America)

Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Session: Host-microbe interactions in lung disease and exacerbations
Session type: Thematic Poster
Number: 2378
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Tovchigrechko (Gaithersburg, United States of America), C. Chiang (Gaithersburg, United States of America), D. Khatry (Gaithersburg, United States of America), C. Emson (Gaithersburg, United States of America), D. Singh (Manchester, United Kingdom), J. Wedzichia (London, United Kingdom), G. Donaldson (London, United Kingdom), C. Brightling (Leicester, United Kingdom), D. Finch (Gaithersburg, United States of America), O. Vaarala (Gaithersburg, United States of America). COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort. 2378

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples
Source: Eur Respir J 2006; 28: Suppl. 50, 824s
Year: 2006

Longitudinal validation of clinical COPD phenotypes identified by cluster analysis
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011

The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma
Source: ERJ Open Res, 6 (1) 00280-2019; 10.1183/23120541.00280-2019
Year: 2020



Association between microbiome and plasma proteome profile in COPD
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020


Cluster analysis revealed differences on quality of life and susceptibility to exacerbation between subpopulations of smokers including COPD
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011


Detailed physiological profiling of patients for a study investigating the airway microbiome
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018




Longitudinal analysis of airway epithelium of COPD subjects reveals unique inflammatory gene networks up-regulated over time
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012


Prediction of longitudinal inflammatory phenotypes using baseline sputum transcriptomics in UBIOPRED
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019


Proteomic derived biomarkers for COPD are present in induced sputum
Source: Eur Respir J 2005; 26: Suppl. 49, 439s
Year: 2005

Identification of clinical phenotypes using cluster analyses in COPD patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


Oral presentation: A comparative analysis of bacterial phylotypes of the lung microbiota of healthy, IPF and transplanted lungs
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013

Sputum transcriptomic analysis of air pollutant signatures: link to asthma severity and phenotype
Source: Virtual Congress 2021 – Environment and air pollution
Year: 2021

Variation of microbiota in COPD patients during exacerbation and posterior stabilization: molecular characterization by metagenomic.
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017



The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes
Source: ERS Lung Science Conference 2016
Year: 2016




Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018


Identification of COPD phenotypes using cluster analysis including exhaled air molecular profiling
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010

Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

The study of airway microbiome and mycobiome of COPD and AECOPD patients
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018


Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019